Please login to the form below

Not currently logged in
Email:
Password:

giant cell tumour of the bone

This page shows the latest giant cell tumour of the bone news and features for those working in and with pharma, biotech and healthcare.

FDA clears Amgen's Xgeva for rare bone condition

FDA clears Amgen's Xgeva for rare bone condition

US approval provides alternative to surgery for use in giant cell tumour of the bone.  . ... The US FDA yesterday gave a green to the use of Amgen's Xgeva (denosumab) to treat adults and some adolescents with giant cell tumour of the bone (GCTB).

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....
Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....